These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 6760959)
1. The role of the peritoneal cavity in successful treatment of a murine lymphoma with chemotherapy and non-specific immunostimulation. Marconi P; Bistoni F; Cassone A; Frati L; Baccarini M; Garaci E; Bonmassar E Cancer Immunol Immunother; 1982; 13(2):128-33. PubMed ID: 6760959 [TBL] [Abstract][Full Text] [Related]
2. Relationships among tumor load, route of tumor inoculation, and response to immunochemotherapy in a murine lymphoma model. Marconi P; Cassone A; Baccarini M; Tissi L; Garaci E; Bonmassar E; Frati L; Bistoni F J Natl Cancer Inst; 1983 Aug; 71(2):299-307. PubMed ID: 6348362 [TBL] [Abstract][Full Text] [Related]
3. [Use of BCG as an immunoadjuvant in combination with antitumor agents in virus-induced leukemia]. Sbaraglia G; Cenci E; Vecchiarelli A; Perito S Boll Soc Ital Biol Sper; 1980 Oct; 56(19):1969-75. PubMed ID: 7459108 [TBL] [Abstract][Full Text] [Related]
4. Combined effects of chemotherapy and host antitumor response in a murine histocompatible lymphoma model. Marconi P; Scaringi L; Tissi L; Puccetti P; Cassone A Int J Immunopharmacol; 1984; 6(3):217-22. PubMed ID: 6378809 [TBL] [Abstract][Full Text] [Related]
5. [The use of BCG as immunoadjuvant in combination with antitumor drugs in a virus induced leukemia. II]. Perito S; Cenci E; Sbaraglia G; Vecchiarelli A Boll Soc Ital Biol Sper; 1980 Dec; 56(23):2511-7. PubMed ID: 7470294 [TBL] [Abstract][Full Text] [Related]
6. Cellular mechanisms underlying the adjuvant activity of Candida albicans in a mouse lymphoma model. Marconi P; Cassone A; Tissi L; Baccarini M; Puccetti P; Garaci E; Bonmassar E; Bistoni F Int J Cancer; 1982 Apr; 29(4):483-8. PubMed ID: 7044994 [TBL] [Abstract][Full Text] [Related]
7. Combined effects of BCG or Candida albicans (CA) with antitumor agents against a virus-induced lymphoma in mice. Bistoni F; Marconi P; Pitzurra M; Frati L; Spreafico F; Goldin A; Bonmassar E Eur J Cancer (1965); 1979 Nov; 15(11):1305-14. PubMed ID: 393515 [No Abstract] [Full Text] [Related]
8. Induction and persistence in vivo of NK/LAK activity by a mannoprotein component of Candida albicans cell wall. Scaringi L; Cornacchione P; Rosati E; Fettucciari K; Rossi R; Marconi P Cell Immunol; 1994 May; 155(2):265-82. PubMed ID: 8181065 [TBL] [Abstract][Full Text] [Related]
9. Treatment of primary radiogenic C57BL mouse cell leukemia/lymphoma by 1,3-bis(2-chloroethyl)-1-nitrosourea chemotherapy and adjuvant cellular therapy. Maruyama Y; Feola JM; Kryscio R Jpn J Cancer Res; 1985 Dec; 76(12):1236-43. PubMed ID: 3005211 [TBL] [Abstract][Full Text] [Related]
10. Immunopotentiation of anticancer chemotherapy by Candida albicans, other yeasts and insoluble glucan in an experimental lymphoma model. Cassone A; Bistoni F; Cenci E; Pesce CD; Tissi L; Marconi P Sabouraudia; 1982 Jun; 20(2):115-25. PubMed ID: 7051368 [TBL] [Abstract][Full Text] [Related]
11. Induction of LAK-like cells in the peritoneal cavity of mice by inactivated Candida albicans. Scaringi L; Cornacchione P; Rosati E; Boccanera M; Cassone A; Bistoni F; Marconi P Cell Immunol; 1990 Sep; 129(2):271-87. PubMed ID: 2166624 [TBL] [Abstract][Full Text] [Related]
12. Drug-mediated increase of tumor immunogenicity in vivo for a new approach to experimental cancer immunotherapy. Giampietri A; Bonmassar A; Puccetti P; Circolo A; Goldin A; Bonmassar E Cancer Res; 1981 Feb; 41(2):681-7. PubMed ID: 7448813 [TBL] [Abstract][Full Text] [Related]
13. Local and systemic immune response to inactivated Candida albicans in mice. Scaringi L; Rosati E; Cornacchione P; Fettucciari K; Sabatini R; Biondi R; Mezzasoma L; Valiani M; D'Errico P; Marconi P Nat Immun; 1995 Sep; 14(5-6):234-49. PubMed ID: 8933818 [TBL] [Abstract][Full Text] [Related]
14. Pyran copolymer as an effective adjuvant to chemotherapy against a murine leukemia and solid tumor. Mohr SJ; Chirigos MA; Fuhrman FS; Pryor JW Cancer Res; 1975 Dec; 35(12):3750-4. PubMed ID: 1192431 [TBL] [Abstract][Full Text] [Related]
16. Schedule-dependent variations in the response of murine P388 leukemia to cyclophosphamide in combination with interferons-alpha/beta. Borden EC; Sidky YA; Hatcher JF; Bryan GT Cancer Res; 1988 May; 48(9):2329-34. PubMed ID: 3356000 [TBL] [Abstract][Full Text] [Related]
17. Augmentation of chemotherapeutically induced remission of a murine leukemia by a chemical immunoadjuvant. Chirigos MA; Pearson JW; Pryor J Cancer Res; 1973 Nov; 33(11):2615-8. PubMed ID: 4795224 [No Abstract] [Full Text] [Related]
18. [Experimental models of immunochemotherapeutic synergism: study of the influence of the treatment schedule]. Circolo A; Bianchi R; Nardelli B; Romani L; Andrielli M Boll Soc Ital Biol Sper; 1979 Oct; 55(19):1974-80. PubMed ID: 554636 [TBL] [Abstract][Full Text] [Related]
20. Eradication of a disseminated mouse lymphoma by 1,3-bis(2-chloroethyl)-1-nitrosourea is immunologically mediated and accompanied by de novo generation of anti-tumor cytotoxicity. Sensi M; Bergomi M; Formelli F; Parmiani G Int J Cancer; 1990 Dec; 46(6):1088-94. PubMed ID: 2249896 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]